NasdaqGS:INSMBiotechs
Is Insmed (INSM) Pricing Reflect Multi Year Cash Flow Potential After 85% One Year Rally
Wondering whether Insmed's current share price lines up with its underlying value, or if expectations have simply run ahead of the story.
The stock last closed at US$150.52, with returns of 1.3% over 7 days, a 6.8% decline over 30 days, a 15.0% decline year to date, and 85.0% over the past year, which naturally raises questions about how much optimism is already in the price.
Recent news coverage has focused heavily on Insmed's progress and prospects in the pharmaceuticals and biotech space...